Search

Search Constraints

You searched for: Author/Creator Dalton, William

Search Results

1. An open‐label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma. (12th March 2015)

2. Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. Issue 3 (4th March 2017)

3. Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide. (20th April 2016)

4. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors. Issue 1 (December 2016)